OtherNov 3, 2026, 04:32 PM
Matinas BioPharma Terminates Advisor Agreement, Pays $562,500 Cash
AI Summary
Matinas BioPharma Holdings, Inc. announced the termination of its agreement with a former financial advisor on November 3, 2026. The original agreement stipulated potential payments of up to $2.0 million in cash and $2.0 million in stock tied to the closing of specific business combinations. As part of the termination settlement, Matinas BioPharma paid the advisor $562,500 in cash, and both parties have executed mutual releases, contingent on certain conditions.
Key Highlights
- Matinas BioPharma Holdings, Inc. terminated its agreement with a former financial advisor.
- The agreement involved potential payments of up to $2.0 million in cash and $2.0 million in stock.
- In connection with the termination, the Company paid the Advisor $562,500 in cash.
- The Company and the Advisor exchanged mutual releases, subject to certain contingencies.
Price Impact
More from MTNB